SCHEMBL32689494

SCHEMBL32689494

NS(=O)(=O)c1ccc(OCCCN2CCNCC2)cc1

nearest known ligand 0.77

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 9/20 0.77
KCNH2 Q12809 6/20 0.75
CA1 P00915 4/20 0.61
CA2 P00918 4/20 0.61
CA9 Q16790 4/20 0.61
CA12 O43570 3/20 0.61
CA7 P43166 3/20 0.61
HRH2 P25021 3/20 0.58
HRH1 P35367 3/20 0.58
TSHR P16473 1/20 0.55
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
ALDH1A1 P00352 2/20 0.52
MAPT P10636 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
KDM4E B2RXH2 1/20 0.50
LMNA P02545 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32689495 0.84 HRH3 (0.79) HRH3KCNH2CA1CA2CA9
SCHEMBL15650142 0.81 HRH3 (0.65) HRH3HRH2HRH1MEN1KMT2A
SCHEMBL7466649 0.80 HRH3 (1.00) HRH3KCNH2CA1CA2CA9
SCHEMBL5231327 0.79 LTA4H (0.57) HRH3KCNH2CA1CA2CA9
Hydrochloric Acid SCHEMBL5935374 0.78 HRH3 (0.63) HRH3KCNH2HRH1TSHR
SCHEMBL9428389 0.78 HRH3 (0.65) HRH3HRH2HRH1MEN1KMT2A
SCHEMBL5753026 0.78 HRH1 (0.65) HRH3HRH2HRH1MEN1KMT2A
SCHEMBL7251585 0.78 HRH3 (0.65) HRH3HRH2HRH1TSHRMEN1
SCHEMBL8410113 0.78 HRH3 (0.65) HRH3KCNH2HRH2HRH1MEN1
SCHEMBL28218809 0.78 ALDH1A1 (0.77) HRH3KCNH2HRH2HRH1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12583818-B2 Compound, preparation method thereof, and use thereof DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION (KR) 2026-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12583818-B2 Compound, preparation method thereof, and use thereof TYRO3, TH, SRMS HRH3 201/4885KCNH2 4556/4885CA1 1920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.